We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

8 hedge funds and large institutions have $159K invested in China Pharma Holdings in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more ownership

Funds ownership: 0% → 0% (+0%)

20% less funds holding

Funds holding: 10 → 8 (-2)

39% less capital invested

Capital invested by funds: $262K → $159K (-$103K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
Virtu Financial
New York
+$18.1K
2
Millennium Management
Millennium Management
New York
+$12.6K
3
Citadel Advisors
Citadel Advisors
Florida
+$9.37K
4
UBS Group
UBS Group
Switzerland
+$803

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$9.5K
2
HF
HRT Financial
New York
-$6K
3
TSS
Two Sigma Securities
New York
-$5K
4
JPLA
Joseph P. Lucia & Associates
New York
-$4K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$68K -$9.5K -71 -10%
BCM
2
Bridgeway Capital Management
Texas
$42K – – –
VF
3
Virtu Financial
New York
$19K +$18.1K +135 +321%
Millennium Management
4
Millennium Management
New York
$15K +$12.6K +94 +196%
Citadel Advisors
5
Citadel Advisors
Florida
$7K +$9.37K +70 New
Two Sigma Advisers
6
Two Sigma Advisers
New York
$5K -$1.2K -9 -16%
UBS Group
7
UBS Group
Switzerland
$3K +$803 +6 +32%
HF
8
HRT Financial
New York
– -$6K -34 Closed
TSS
9
Two Sigma Securities
New York
– -$5K -27 Closed
JPLA
10
Joseph P. Lucia & Associates
New York
– -$4K -18 Closed

CPHI Hedge Fund Activity: Q2 2022 in Review

8 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2022, worth a combined $159K — down 39% from $262K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CPHI and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Virtu Financial, adding an estimated $18.1K. The largest seller was Renaissance Technologies, cutting an estimated $9.5K.

  • 8 institutional investors held China Pharma Holdings (CPHI) as of Q2 2022, down from 10 in Q1 2022.
  • Funds reported $159K of China Pharma Holdings stock for Q2 2022, down 39% quarter-over-quarter.
  • 1 fund opened new China Pharma Holdings positions in Q2 2022 and 3 closed out, a net change of -2 holders.
  • The largest China Pharma Holdings buyer in Q2 2022 was Virtu Financial, an estimated $18.1K added.
  • The largest China Pharma Holdings seller in Q2 2022 was Renaissance Technologies, an estimated $9.5K sold.

Based on aggregated 13F filings for Q2 2022.